Anti-CD20 antibody as Initial therapy for adult-onset minimal change disease with nephrotic syndrome：a case series report

loading page

12 Oct 2024Submitted to Clinical Case Reports

15 Oct 2024Submission Checks Completed

15 Oct 2024Assigned to Editor

21 Oct 2024Reviewer(s) Assigned

25 Oct 2024Review(s) Completed, Editorial Evaluation Pending

28 Oct 2024Editorial Decision: Revise Minor

01 Nov 20241st Revision Received